System Biosciences (SBI) recognizes the need to invest in and maintain a comprehensive intellectual property (IP) portfolio that protects its unique and novel approaches to understanding gene and protein function in complex biological systems. SBI currently has a number of pending patents and licensing agreements related to lentiviral vectors, effector library technology, lentiviral reporter vectors, and fluorescent reporters. For information concerning our IP position around these or other technologies, please contact us.
Supplementing this IP investment, SBI has an active in-licensing program for obtaining key complementary technologies that enhance the utility of our systems. If you have technology that might interest us, please let us know.